Diet and Lifestyle in Nonalcoholic Fatty Liver Disease

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease

Saved in:

Bibliographic Details
Main Authors:	Roberto Martínez-Beamonte, Sergio Acín, Adela Ramírez-Torres, María Ángeles Navarro
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2020/3495082
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long-Term Effects of Metformin and Lifestyle Modification on Nonalcoholic Fatty Liver Disease Obese Adolescents
by: Lian Tock, et al.
Published: (2010-01-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01)

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
by: Jinsheng Yu, et al.
Published: (2016-01-01)

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease
by: Camelia Cojocariu, et al.
Published: (2020-01-01)

Deficiency in Galectin-3 Promotes Hepatic Injury in CDAA Diet-Induced Nonalcoholic Fatty Liver Disease
by: Kazuhiro Nomoto, et al.
Published: (2012-01-01)

Ameliorative Potential of Tamarindus indica on High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats
by: Suja Rani Sasidharan, et al.
Published: (2014-01-01)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
by: Abdelfattah El Ouaamari, et al.
Published: (2013-01-01)

Nonalcoholic Fatty Liver Disease in Patients Investigated for Elevated Liver Enzymes
by: Krikor Kichian, et al.
Published: (2003-01-01)

Nonalcoholic Fatty Liver Disease: A Clinical Approach and Review
by: Maitreyi Raman, et al.
Published: (2006-01-01)

Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children
by: Anna Alisi, et al.
Published: (2011-01-01)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Elena Buzzetti, et al.
Published: (2015-01-01)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
by: Ana-Maria Singeap, et al.
Published: (2021-01-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
by: Elena Paschetta, et al.
Published: (2015-01-01)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
by: Ivana Mikolasevic, et al.
Published: (2020-01-01)

Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats
by: Şule Demir, et al.
Published: (2016-01-01)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
by: Caihua Wang, et al.
Published: (2019-01-01)

Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
by: Rajalingham Sakthiswary, et al.
Published: (2014-01-01)

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease
by: Bai Li, et al.
Published: (2022-01-01)

The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
by: Said A Al-Busafi, et al.
Published: (2012-01-01)

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
by: Hongjie Ou, et al.
Published: (2019-01-01)

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
by: Wenxia Lu, et al.
Published: (2016-01-01)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
by: Stefano Bibbò, et al.
Published: (2018-01-01)

Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population
by: Maritza Pérez-Mayorga, et al.
Published: (2022-01-01)

Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Seon Young Ahn, et al.
Published: (2020-01-01)

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
by: Hannes Hagström, et al.
Published: (2018-01-01)

The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies
by: Hessam Yaghmaei, et al.
Published: (2024-01-01)

RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease
by: Kamyar Asadipooya, et al.
Published: (2019-01-01)

Time Course of the Development of Nonalcoholic Fatty Liver Disease in the Otsuka Long-Evans Tokushima Fatty Rat
by: Yi-Sun Song, et al.
Published: (2013-01-01)

A High-Fat, High-Fructose Diet Induces Antioxidant Imbalance and Increases the Risk and Progression of Nonalcoholic Fatty Liver Disease in Mice
by: Kanokwan Jarukamjorn, et al.
Published: (2016-01-01)

Effect of Alkaloids from Nelumbinis Plumula against Insulin Resistance of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
by: Yong Xie, et al.
Published: (2016-01-01)

Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis
by: Changzhou Cai, et al.
Published: (2021-01-01)

Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice
by: Yan Yang, et al.
Published: (2021-01-01)

Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
by: Lili Yang, et al.
Published: (2017-01-01)

Understanding the Role of Exercise in Nonalcoholic Fatty Liver Disease: ERS-Linked Molecular Pathways
by: Yong Zou, et al.
Published: (2020-01-01)

Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur”
by: Abdulrahman Ismaiel, et al.
Published: (2020-01-01)

Increasing Whole Grain Intake as Part of Prevention and Treatment of Nonalcoholic Fatty Liver Disease
by: Alastair B. Ross, et al.
Published: (2013-01-01)

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
by: Hwa Young Ahn, et al.
Published: (2018-01-01)

Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
by: Julia Uhanova, et al.
Published: (2016-01-01)